Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy Deferral.
Dudzinski SO, Cabanillas ME, Hamidi S, Marczyk VR, Busaidy NL, Dadu R, Welsh J, Hu MI, Gunn GB, Wang C, Waguespack SG, Phan J, Beckham TH, Chang JY, Sherman SI, Reddy JP, Ying AK, O'Reilly MS, Chen A, Lee A, Gandhi SJ, Liao Z, Ludmir EB, Nguyen QN, Lin SH, Zafereo ME, Ning MS. Dudzinski SO, et al. Among authors: dadu r. J Natl Compr Canc Netw. 2024 Dec 11:1-7. doi: 10.6004/jnccn.2024.7072. Online ahead of print. J Natl Compr Canc Netw. 2024. PMID: 39662038
[18F]-Fluorodeoxyglucose Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma Following BRAF-Targeted Therapy.
Dagher SA, Learned KO, Dagher R, Wang JR, Zhao X, Hosseini SM, Maniakas A, Cabanillas ME, Busaidy NL, Dadu R, Iyer P, Zafereo ME, Khalaf AM. Dagher SA, et al. Among authors: dadu r. AJNR Am J Neuroradiol. 2024 Nov 21:ajnr.A8588. doi: 10.3174/ajnr.A8588. Online ahead of print. AJNR Am J Neuroradiol. 2024. PMID: 39572200
Patterns of loco-regional progression and patient outcomes after definitive-dose radiation therapy for anaplastic thyroid cancer.
Bronk JK, Augustyn A, Mohamed ASR, David Fuller C, Garden AS, Moreno AC, Lee A, Morrison WH, Phan J, Reddy JP, Rosenthal DI, Spiotto MT, Frank SJ, Dadu R, Busaidy N, Zafereo M, Wang JR, Maniakas A, Ferrarotto R, Iyer PC, Cabanillas ME, Gunn GB. Bronk JK, et al. Among authors: dadu r. Radiother Oncol. 2024 Nov 1;202:110602. doi: 10.1016/j.radonc.2024.110602. Online ahead of print. Radiother Oncol. 2024. PMID: 39489425 Free article.
Anti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial.
Cabanillas ME, Dadu R, Ferrarotto R, Gule-Monroe M, Liu S, Fellman B, Williams MD, Zafereo M, Wang JR, Lu C, Ning M, McKinley BA, Woodman SE, Duose D, Gunn GB, Busaidy NL; Rare Tumor Initiative Team. Cabanillas ME, et al. Among authors: dadu r. JAMA Oncol. 2024 Oct 24:e244729. doi: 10.1001/jamaoncol.2024.4729. Online ahead of print. JAMA Oncol. 2024. PMID: 39446377 Free PMC article.
Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement.
Hamidi S, Dadu R, Zafereo ME, Ferrarotto R, Wang JR, Maniakas A, Gunn GB, Lee A, Spiotto MT, Iyer PC, Sousa LG, Akhave NS, Ahmed S, Learned KO, Lu C, Lai SY, Williams M, Hosseini SM, Busaidy NL, Cabanillas ME. Hamidi S, et al. Among authors: dadu r. JAMA Oncol. 2024 Sep 1;10(9):1264-1271. doi: 10.1001/jamaoncol.2024.2133. JAMA Oncol. 2024. PMID: 38990526
Next-Generation Sequencing in Sporadic Medullary Thyroid Cancer Patients: Mutation Profile and Disease Aggressiveness.
Shirali AS, Hu MI, Chiang YJ, Graham PH, Fisher SB, Sosa JA, Perrier N, Brown S, Holla VR, Dadu R, Busaidy N, Sherman SI, Cabanillas M, Waguespack SG, Zafereo ME, Grubbs EG. Shirali AS, et al. Among authors: dadu r. J Endocr Soc. 2024 Apr 24;8(6):bvae048. doi: 10.1210/jendso/bvae048. eCollection 2024 Apr 6. J Endocr Soc. 2024. PMID: 38660141 Free PMC article.
95 results